178 related articles for article (PubMed ID: 24339940)
21. Discovery and characterization of an iminocoumarin scaffold as an inhibitor of MEKK2 (MAP3K2).
Ahmad S; St Hilaire VR; Dandepally SR; Johnson GL; Williams AL; Scott JE
Biochem Biophys Res Commun; 2018 Jan; 496(1):205-211. PubMed ID: 29309787
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-27a promotes proliferation, migration and invasion by targeting MAP2K4 in human osteosarcoma cells.
Pan W; Wang H; Jianwei R; Ye Z
Cell Physiol Biochem; 2014; 33(2):402-12. PubMed ID: 24556602
[TBL] [Abstract][Full Text] [Related]
23. Virtual screening filters for the design of type II p38 MAP kinase inhibitors: a fragment based library generation approach.
Badrinarayan P; Sastry GN
J Mol Graph Model; 2012 Apr; 34():89-100. PubMed ID: 22306417
[TBL] [Abstract][Full Text] [Related]
24. Development and implementation of a 384-well homogeneous fluorescence intensity high-throughput screening assay to identify mitogen-activated protein kinase phosphatase-1 dual-specificity protein phosphatase inhibitors.
Johnston PA; Foster CA; Shun TY; Skoko JJ; Shinde S; Wipf P; Lazo JS
Assay Drug Dev Technol; 2007 Jun; 5(3):319-32. PubMed ID: 17638532
[TBL] [Abstract][Full Text] [Related]
25. Receptor tyrosine kinase inhibitors block proliferation of TGEV mainly through p38 mitogen-activated protein kinase pathways.
Dong W; Xie W; Liu Y; Sui B; Zhang H; Liu L; Tan Y; Tong X; Fu ZF; Yin P; Fang L; Peng G
Antiviral Res; 2020 Jan; 173():104651. PubMed ID: 31751591
[TBL] [Abstract][Full Text] [Related]
26. High throughput screens yield small molecule inhibitors of Leishmania CRK3:CYC6 cyclin-dependent kinase.
Walker RG; Thomson G; Malone K; Nowicki MW; Brown E; Blake DG; Turner NJ; Walkinshaw MD; Grant KM; Mottram JC
PLoS Negl Trop Dis; 2011 Apr; 5(4):e1033. PubMed ID: 21483720
[TBL] [Abstract][Full Text] [Related]
27. Development of an in vitro screening assay for PIP5K1α lipid kinase and identification of potent inhibitors.
Strätker K; Haidar S; Amesty Á; El-Awaad E; Götz C; Estévez-Braun A; Jose J
FEBS J; 2020 Jul; 287(14):3042-3064. PubMed ID: 31876381
[TBL] [Abstract][Full Text] [Related]
28. Map2k4δ - identification and functional characterization of a novel Map2k4 splice variant.
Haeusgen W; Tueffers L; Herdegen T; Waetzig V
Biochim Biophys Acta; 2014 May; 1843(5):875-84. PubMed ID: 24487067
[TBL] [Abstract][Full Text] [Related]
29. Nuclear export inhibitors and kinase inhibitors identified using a MAPK-activated protein kinase 2 redistribution screen.
Almholt DL; Loechel F; Nielsen SJ; Krog-Jensen C; Terry R; Bjørn SP; Pedersen HC; Praestegaard M; Møller S; Heide M; Pagliaro L; Mason AJ; Butcher S; Dahl SW
Assay Drug Dev Technol; 2004 Feb; 2(1):7-20. PubMed ID: 15090206
[TBL] [Abstract][Full Text] [Related]
30. Modeling MEK4 Kinase Inhibitors through Perturbed Electrostatic Potential Charges.
Mishra RK; Deibler KK; Clutter MR; Vagadia PP; O'Connor M; Schiltz GE; Bergan R; Scheidt KA
J Chem Inf Model; 2019 Oct; 59(10):4460-4466. PubMed ID: 31566378
[TBL] [Abstract][Full Text] [Related]
31. A 1536-well fluorescence polarization assay to screen for modulators of the MUSASHI family of RNA-binding proteins.
Minuesa G; Antczak C; Shum D; Radu C; Bhinder B; Li Y; Djaballah H; Kharas MG
Comb Chem High Throughput Screen; 2014; 17(7):596-609. PubMed ID: 24912481
[TBL] [Abstract][Full Text] [Related]
32. Discovery of diverse small molecule chemotypes with cell-based PKD1 inhibitory activity.
Sharlow ER; Mustata Wilson G; Close D; Leimgruber S; Tandon M; Reed RB; Shun TY; Wang QJ; Wipf P; Lazo JS
PLoS One; 2011; 6(10):e25134. PubMed ID: 21998636
[TBL] [Abstract][Full Text] [Related]
33. Discovery and Structure-Activity Relationship Study of (
Manz TD; Sivakumaren SC; Ferguson FM; Zhang T; Yasgar A; Seo HS; Ficarro SB; Card JD; Shim H; Miduturu CV; Simeonov A; Shen M; Marto JA; Dhe-Paganon S; Hall MD; Cantley LC; Gray NS
J Med Chem; 2020 May; 63(9):4880-4895. PubMed ID: 32298120
[TBL] [Abstract][Full Text] [Related]
34. MAP2K4 interacts with Vimentin to activate the PI3K/AKT pathway and promotes breast cancer pathogenesis.
Liu S; Huang J; Zhang Y; Liu Y; Zuo S; Li R
Aging (Albany NY); 2019 Nov; 11(22):10697-10710. PubMed ID: 31761784
[TBL] [Abstract][Full Text] [Related]
35. Cdc25B dual-specificity phosphatase inhibitors identified in a high-throughput screen of the NIH compound library.
Johnston PA; Foster CA; Tierno MB; Shun TY; Shinde SN; Paquette WD; Brummond KM; Wipf P; Lazo JS
Assay Drug Dev Technol; 2009 Jun; 7(3):250-65. PubMed ID: 19530895
[TBL] [Abstract][Full Text] [Related]
36. A comparative study of fragment screening methods on the p38α kinase: new methods, new insights.
Pollack SJ; Beyer KS; Lock C; Müller I; Sheppard D; Lipkin M; Hardick D; Blurton P; Leonard PM; Hubbard PA; Todd D; Richardson CM; Ahrens T; Baader M; Hafenbradl DO; Hilyard K; Bürli RW
J Comput Aided Mol Des; 2011 Jul; 25(7):677-87. PubMed ID: 21732248
[TBL] [Abstract][Full Text] [Related]
37. Application of Eukaryotic Elongation Factor-2 Kinase (eEF-2K) for Cancer Therapy: Expression, Purification, and High-Throughput Inhibitor Screening.
Tavares CD; Devkota AK; Dalby KN; Cho EJ
Methods Mol Biol; 2016; 1360():19-33. PubMed ID: 26501899
[TBL] [Abstract][Full Text] [Related]
38. Pro-life role for c-Jun N-terminal kinase and p38 mitogen-activated protein kinase at rostral ventrolateral medulla in experimental brain stem death.
Chang AY
J Biomed Sci; 2012 Nov; 19(1):96. PubMed ID: 23157661
[TBL] [Abstract][Full Text] [Related]
39. Discovery of novel pyruvate dehydrogenase kinases inhibitors by screening of an in-house small molecule library for anti-lung cancer therapeutics.
Guo F; Zhao S; Li X
Bioorg Med Chem Lett; 2019 Jan; 29(2):291-296. PubMed ID: 30470491
[TBL] [Abstract][Full Text] [Related]
40. Development and implementation of a miniaturized high-throughput time-resolved fluorescence energy transfer assay to identify small molecule inhibitors of polo-like kinase 1.
Sharlow ER; Leimgruber S; Shun TY; Lazo JS
Assay Drug Dev Technol; 2007 Dec; 5(6):723-35. PubMed ID: 18181689
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]